These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16952163

  • 1. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P.
    Synapse; 2006 Dec 01; 60(7):543-52. PubMed ID: 16952163
    [Abstract] [Full Text] [Related]

  • 2. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY, Li Z, Kaneda Y, Ichikawa J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct 01; 27(7):1159-72. PubMed ID: 14642974
    [Abstract] [Full Text] [Related]

  • 3. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 01; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

  • 5. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 15; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

  • 7. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T, Meltzer HY, Ichikawa J.
    J Pharmacol Exp Ther; 1999 Feb 15; 288(2):774-81. PubMed ID: 9918588
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacology of second-generation antipsychotics: a validity of the serotonin-dopamine hypothesis].
    Kuroki T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct 15; 24(5):257-64. PubMed ID: 15658501
    [Abstract] [Full Text] [Related]

  • 9. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Ohno Y, Ishida-Tokuda K, Ishibashi T, Sakamoto H, Tagashira R, Horisawa T, Yabuuti K, Matsumoto K, Kawabe A, Nakamura M.
    Pol J Pharmacol; 1997 Aug 15; 49(4):213-9. PubMed ID: 9437764
    [Abstract] [Full Text] [Related]

  • 10. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ, Schotte A, Docter GJ, Voorn P.
    Synapse; 1998 Apr 15; 28(4):302-12. PubMed ID: 9517839
    [Abstract] [Full Text] [Related]

  • 11. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE.
    Psychopharmacology (Berl); 1996 Mar 15; 124(1-2):57-73. PubMed ID: 8935801
    [Abstract] [Full Text] [Related]

  • 12. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T, Nagao N, Nakahara T.
    Prog Brain Res; 2008 Mar 15; 172():199-212. PubMed ID: 18772034
    [Abstract] [Full Text] [Related]

  • 13. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):83-97. PubMed ID: 8996185
    [Abstract] [Full Text] [Related]

  • 14. S-16924, a novel, potential antipsychotic with marked serotonin1A agonist properties. IV. A drug discrimination comparison with clozapine.
    Millan MJ, Schreiber R, Monneyron S, Denorme B, Melon C, Queriaux S, Dekeyne A.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):427-36. PubMed ID: 10087034
    [Abstract] [Full Text] [Related]

  • 15. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY.
    Clin Neurosci; 1995 Apr 15; 3(2):64-75. PubMed ID: 7583621
    [Abstract] [Full Text] [Related]

  • 16. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun 15; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 17. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA, Piercey MF.
    J Neural Transm (Vienna); 1998 Jun 15; 105(6-7):749-67. PubMed ID: 9826116
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T.
    Synapse; 1992 Jan 15; 10(1):25-33. PubMed ID: 1346943
    [Abstract] [Full Text] [Related]

  • 19. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
    Chaki S, Funakoshi T, Yoshikawa R, Okuyama S, Kumagai T, Nakazato A, Nagamine M, Tomisawa K.
    Neuropharmacology; 1999 Aug 15; 38(8):1185-94. PubMed ID: 10462131
    [Abstract] [Full Text] [Related]

  • 20. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A, Billiras R, Cistarelli L, Millan MJ.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):141-52. PubMed ID: 15589344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.